{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T14:43:37Z","timestamp":1766760217781,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00223-021-00822-7","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T15:03:37Z","timestamp":1614006217000},"page":"104-109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hepatitis C-Associated Osteosclerosis: Improvement After Treatment with Sofosbuvir, Daclatasvir, and Ibandronate: Case Report and Literature Review"],"prefix":"10.1007","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5475-601X","authenticated-orcid":false,"given":"Maria Carolina","family":"de Camargo Vieira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5213-2983","authenticated-orcid":false,"given":"Wagner Rodrigo Brida","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5107-0418","authenticated-orcid":false,"given":"Ricardo Ayello","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5344-3214","authenticated-orcid":false,"given":"Fabiana Siroma","family":"Callegaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9186-2834","authenticated-orcid":false,"given":"Marise","family":"Lazaretti-Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2669-4245","authenticated-orcid":false,"given":"Sergio Setsuo","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"key":"822_CR1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/0002-9343(92)90165-8","volume":"93","author":"DT Villareal","year":"1992","unstructured":"Villareal DT, Murphy WA, Teitelbaum SL, Arens MQ, Whyte MP (1992) Painful diffuse osteosclerosis after intravenous drug abuse. Am J Med 93:371\u2013381. https:\/\/doi.org\/10.1016\/0002-9343(92)90165-8","journal-title":"Am J Med"},{"key":"822_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/s8756-3282(96)00304-3","volume":"19","author":"T Diamond","year":"1996","unstructured":"Diamond T, Depczynski B (1996) Acquired osteosclerosis associated with intravenous drug use and hepatitis C infection. Bone 19:679\u2013683. https:\/\/doi.org\/10.1016\/s8756-3282(96)00304-3","journal-title":"Bone"},{"key":"822_CR3","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/jbmr.5650110417]","volume":"11","author":"MP Whyte","year":"1996","unstructured":"Whyte MP, Teitelbaum SL, Reinus WR (1996) Doubling skeletal mass during adult life: the syndrome of diffuse osteosclerosis after intravenous drug abuse. J Bone Miner Res 11:554\u2013558. https:\/\/doi.org\/10.1002\/jbmr.5650110417]","journal-title":"J Bone Miner Res"},{"key":"822_CR4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.4158\/EP.2.4.296","volume":"2","author":"D Bergman","year":"1996","unstructured":"Bergman D, Einhorn TI, Forster G (1996) Stone bone syndrome\u2013diffuse sclerosis of bone: a newly described clinical disorder. EndocrPract 2:296\u2013296. https:\/\/doi.org\/10.4158\/EP.2.4.296","journal-title":"EndocrPract"},{"key":"822_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/s0002-9343(97)89507-1]","volume":"102","author":"MP Whyte","year":"1997","unstructured":"Whyte MP, Reasner CA (1997) Hepatitis C-associated osteosclerosis after blood transfusion. Am J Med 102:219\u2013220. https:\/\/doi.org\/10.1016\/s0002-9343(97)89507-1]","journal-title":"Am J Med"},{"key":"822_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/s0002-9343(97)00139-3]","volume":"103","author":"AA Hassoun","year":"1997","unstructured":"Hassoun AA, Nippoldt TB, Tiegs RD, Khosla S (1997) Hepatitis C-associated osteosclerosis: an unusual syndrome of acquired osteosclerosis in adults. Am J Med 103:70\u201373. https:\/\/doi.org\/10.1016\/s0002-9343(97)00139-3]","journal-title":"Am J Med"},{"key":"822_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1210\/jcem.83.1.4521]","volume":"83","author":"JL Shaker","year":"1998","unstructured":"Shaker JL, Reinus WR, Whyte MP (1998) Hepatitis C-associated osteosclerosis: late onset after blood transfusion in an elderly woman. J ClinEndocrinolMetab 83:93\u201398. https:\/\/doi.org\/10.1210\/jcem.83.1.4521]","journal-title":"J ClinEndocrinolMetab"},{"key":"822_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/art.10770]","volume":"48","author":"S Wakitani","year":"2003","unstructured":"Wakitani S, Hattori T, Nakaya H, Chae Y, Murata N, Tanigami A (2003) Clinical images: Hepatitis C\u2013associated osteosclerosis. Arthritis Rheum 48:268\u2013268. https:\/\/doi.org\/10.1002\/art.10770]","journal-title":"Arthritis Rheum"},{"key":"822_CR9","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1007\/s00198-005-1858-8","volume":"16","author":"CE Fiore","year":"2005","unstructured":"Fiore CE, Riccobene S, Mangiafico R, Santoro F, Pennisi P (2005) Hepatitis C-associated osteosclerosis (HCAO): report of a new case with involvement of the OPG\/RANKL system. OsteoporosInt 16:2180\u20132184. https:\/\/doi.org\/10.1007\/s00198-005-1858-8","journal-title":"OsteoporosInt"},{"key":"822_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s10067-004-1031-3","volume":"24","author":"P Manganelli","year":"2005","unstructured":"Manganelli P, Giuliani N, Fietta P, Mancini C, Lazzaretti M, Pollini A, Quaini F, Pedrazzoni M (2005) OPG\/RANKL system imbalance in a case of hepatitis C-associated osteosclerosis: the pathogenetic key? ClinRheumatol 24:296\u2013300. https:\/\/doi.org\/10.1007\/s10067-004-1031-3","journal-title":"ClinRheumatol"},{"key":"822_CR11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1055\/s-2006-924399","volume":"114","author":"H Kaji","year":"2006","unstructured":"Kaji H, Naito J, Sowa H, Sugimoto T, Chihara K (2006) Serum soluble factors induce the proliferation, alkaline phosphatase activity and transforming growth factor-beta signal in osteoblastic cells in the patient with hepatitis C-associated osteosclerosis. ExpClinEndocrinol Diabetes 114:599\u2013604. https:\/\/doi.org\/10.1055\/s-2006-924399","journal-title":"ExpClinEndocrinol Diabetes"},{"key":"822_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1507\/endocrj.k04-131","volume":"53","author":"T Tanaka","year":"2006","unstructured":"Tanaka T, Oki S, Muro S, Tanaka K, Hashimoto J (2006) A case of hepatitis C-associated osteosclerosis in an elderly Japanese man. Endocr J 53:393\u2013399. https:\/\/doi.org\/10.1507\/endocrj.k04-131","journal-title":"Endocr J"},{"key":"822_CR13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00256-008-0471-2","volume":"37","author":"KM Schwartz","year":"2008","unstructured":"Schwartz KM, Skinner JA (2008) Hepatitis C-associated osteosclerosis: a case report. Skeletal Radiol 37:679\u2013681. https:\/\/doi.org\/10.1007\/s00256-008-0471-2","journal-title":"Skeletal Radiol"},{"key":"822_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12328-011-0228-7","volume":"4","author":"S Shakado","year":"2011","unstructured":"Shakado S, Akehi Y, Yotsumoto K, Fukunaga A, Kuno S, Tanaka T, Sakurai K, Iwashita H, Ueda S, Hirano G, Yokoyama K, Morihara D, Nishizawa S, Sakamoto M, Anan A, Takeyama Y, Irie M, Iwata K, Sohda T, Sakisaka S (2011) A case of hepatitis C-associated osteosclerosis that was improved with the combination therapy of peginterferon alfa-2b and ribavirin. Clin J Gastroenterol 4:255\u2013261. https:\/\/doi.org\/10.1007\/s12328-011-0228-7","journal-title":"Clin J Gastroenterol"},{"key":"822_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jbspin.2011.02.016","volume":"78","author":"R-M Javier","year":"2011","unstructured":"Javier R-M, de Vernejoul M-C, Afif N, Kuntz J-L, Sibilia J (2011) Skeletal recovery from hepatitis C-associated osteosclerosis (HCAO) following antiviral treatment. Joint Bone Spine 78:409\u2013411. https:\/\/doi.org\/10.1016\/j.jbspin.2011.02.016","journal-title":"Joint Bone Spine"},{"key":"822_CR16","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.2169\/internalmedicine.50.4675","volume":"50","author":"Y Hataya","year":"2011","unstructured":"Hataya Y, Komatsu Y, Chusho H, Kirishima T, Shintani H, Morimoto T (2011) A case of hepatitis C-associated osteosclerosis with xanthogranulomatouscholecystitis. Intern Med 50:1703\u20131708. https:\/\/doi.org\/10.2169\/internalmedicine.50.4675","journal-title":"Intern Med"},{"key":"822_CR17","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00256-014-1882-x","volume":"43","author":"N Epperla","year":"2014","unstructured":"Epperla N, McKiernan FE (2014) An uncommon cause of acquired osteosclerosis in adults: hepatitis C-associated osteosclerosis. Skeletal Radiol 43:1313\u20131318. https:\/\/doi.org\/10.1007\/s00256-014-1882-x","journal-title":"Skeletal Radiol"},{"key":"822_CR18","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2169\/internalmedicine.54.3448","volume":"54","author":"C Serraino","year":"2015","unstructured":"Serraino C, Melchio R, Silvestri A, Borretta V, Pomero F, Fenoglio L (2015) Hepatitis C-associated osteosclerosis: a new case with long-term follow-up and a review of the literature. Intern Med 54:777\u2013783. https:\/\/doi.org\/10.2169\/internalmedicine.54.3448","journal-title":"Intern Med"},{"key":"822_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1530\/EDM-16-0097","volume":"2016","author":"N Miyamura","year":"2016","unstructured":"Miyamura N, Nishida S, Itasaka M, Matsuda H, Ohtou T, Yamaguchi Y, Inaba D, Tamiya S, Nakano T (2016) A case of hepatitis C-associated osteosclerosis: accelerated bone turnover controlled by pulse steroid therapy. Endocrinol Diabetes Metab Case Rep 2016:16\u20130097. https:\/\/doi.org\/10.1530\/EDM-16-0097","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"822_CR20","first-page":"769","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"MP Whyte","year":"2013","unstructured":"Whyte MP (2013) Sclerosing bone disorders. In: Rossen CJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 8th edn. Wiley, New York, pp 769\u2013785","edition":"8"},{"key":"822_CR21","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1172\/jci1111","volume":"101","author":"S Khosla","year":"1998","unstructured":"Khosla S, Hassoun A, Baker B, Liu F, Zein N, Whyte M, Reasner C, Nippoldt TB, Tiegs RD, Hintz RL, Conover CA (1998) Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults. J ClinInvestig 101:2165\u20132173. https:\/\/doi.org\/10.1172\/jci1111","journal-title":"J ClinInvestig"},{"key":"822_CR22","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1210\/jcem.87.8.8783]","volume":"87","author":"S Khosla","year":"2002","unstructured":"Khosla S, Ballard JF, Conover CA (2002) Use of site-specific antibodies to characterize the circulating form of big insulin-like growth factor I in patients with hepatitis-C associated osteosclerosis. J ClinEndocrinolMetab 87:3867\u20133870. https:\/\/doi.org\/10.1210\/jcem.87.8.8783]","journal-title":"J ClinEndocrinolMetab"},{"key":"822_CR23","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00705-001-0943-x","volume":"156","author":"J Liu","year":"2011","unstructured":"Liu J, Wang Z, Tang J, Tang R, Shan X, Zhang W, Chen Q, Zhou F, Chen K, Huang A, Tang N (2011) Hepatitis C virus core protein activates Wnt\/\u00df-catenin signaling through multiple regulation of upstream molecules in the SMMC-7721 cell line. Arch Virol 156:1013\u20131023. https:\/\/doi.org\/10.1007\/s00705-001-0943-x","journal-title":"Arch Virol"},{"key":"822_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1623","author":"J van Doorn","year":"2020","unstructured":"van Doorn J (2020) Insulin-like growth factor-II and bioactive proteins containing a part of the E-domain of pro-insulin-like growth factor-II. BioFactors. https:\/\/doi.org\/10.1002\/biof.1623","journal-title":"BioFactors"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-021-00822-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-021-00822-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-021-00822-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T06:02:57Z","timestamp":1624946577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-021-00822-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["822"],"URL":"https:\/\/doi.org\/10.1007\/s00223-021-00822-7","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"type":"print","value":"0171-967X"},{"type":"electronic","value":"1432-0827"}],"subject":[],"published":{"date-parts":[[2021,2,22]]},"assertion":[{"value":"8 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Maria Carolina de Camargo Vieira, Wagner Rodrigo Brida Gon\u00e7alves, Ricardo Ayello Guerra, Fabiana Siroma Callegaro, Marise Lazaretti-Castro, Sergio Setsuo Maeda have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Research Ethics Committee of the Federal University of S\u00e3o Paulo (UNIFESP).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from the participant included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}